A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 1, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2023, filed Sep 25, 2023. Each column of the statement tables below links to the filing it was taken from.
ENDEXX CORP (EDXC) reported $2.1M in revenue for fiscal year 2022, up 228.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Sales and gross margin recovered in FY2022, but persistent losses and liabilities larger than assets still define how this business is financed.
Revenue recovery reached$2.1M in FY2022 from$651K in FY2021, but the improvement did not yet translate into operating leverage. The gross margin swing from-52.9% to55.8% still left operating margin at-183.2% , showing that overhead continued to absorb the gross profit.
Cash conversion remains negative: FY2022 operating cash flow was
The balance sheet is structurally strained: liabilities of
Financial Health Signals
ENDEXX CORP does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
ENDEXX CORP scores -6.80, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($2.1M) relative to total liabilities ($23.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
ENDEXX CORP passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
ENDEXX CORP reported a net loss of $4.9M while operations used $2.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.
ENDEXX CORP reported an operating loss of $3.9M against $1.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
ENDEXX CORP generated $119K in revenue in Q3 2023. This represents a decrease of 71.6% from the same quarter a year earlier. Against the prior quarter it is down 95.8%.
ENDEXX CORP's EBITDA was -$748K in Q3 2023, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 19.4% from the same quarter a year earlier. Against the prior quarter it is down 80.4%.
ENDEXX CORP reported -$1.8M in net income in Q3 2023. Against the prior quarter it is down 28.8%.
Not reported for Q3 2023.
Cash & Balance Sheet
ENDEXX CORP held $24K in cash against $20.0M in long-term debt as of Q3 2023.
Not reported for Q3 2023.
Not reported for Q3 2023.
Margins & Returns
ENDEXX CORP's gross margin was 3.5% in Q3 2023, indicating the percentage of revenue retained after direct costs. This is down 46.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 10.4 percentage points.
Not shown for Q3 2023: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q3 2023: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for Q3 2023.
Capital Allocation
ENDEXX CORP invested $700 in research and development in Q3 2023. This represents a decrease of 74.4% from the same quarter a year earlier. Against the prior quarter it is down 52.9%.
Not reported for Q3 2023.
Not reported for Q3 2023.
EDXC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-Q | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $119K-71.6% | $2.8M+1012.9% | $492K+79.1% | $1.2M+407.9% | $418K+246.1% | $255K+73.8% | $275K+84.6% | $234K |
| Cost of Revenue | $114K-45.8% | $2.4M+2990.6% | $358K+38.5% | $218K+260.7% | $211K-45.1% | $79K-72.7% | $258K+409.4% | -$136K |
| Gross Profit | $4K-98.0% | $394K+124.3% | $134K+723.5% | $794K+312.1% | $207K+178.2% | $176K+202.2% | $16K-83.4% | $193K |
| R&D Expenses | $700-74.4% | $1K-91.0% | $3K+30.2% | $5K+72.6% | $3K-24.7% | $17K+4264.7% | $2K-21.7% | $3K |
| SG&A Expenses | $180K+6.0% | $303K+49.6% | $399K+56.6% | $965K+437.1% | $170K-22.9% | $202K-22.0% | $255K+27.2% | $180K |
| Operating Income | -$750K-18.5% | -$417K+27.6% | -$1.2M+16.0% | -$1.3M+10.9% | -$633K+69.9% | -$576K+36.5% | -$1.4M-54.3% | -$1.4M |
| EBITDA | -$748K-19.4% | -$415K+27.4% | -$1.2M+15.9% | -$1.3M+10.8% | -$626K+70.1% | -$571K+36.7% | -$1.4M-54.6% | -$1.4M |
| Interest Expense | $327K-27.4% | $271K+14.8% | $304K+25.5% | $313K+36.4% | $450K+96.9% | $236K+5.3% | $242K-9.6% | $230K |
| Net Income | -$1.8M | -$1.4M+48.6% | -$597K+63.8% | N/A | N/A | -$2.8M-96.6% | -$1.6M-51.1% | -$1.9M |
| EPS (Basic) | $0.00+100.0% | $0.00+100.0% | $0.00 | $0.02 | -$0.02-100.0% | -$0.01 | $0.00 | $0.00 |
Not reported in any period shown, so not listed: Income Tax, EPS (Diluted), Diluted Shares (Avg).
EDXC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-Q | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.2M+697.7% | $12.7M+617.1% | $12.9M+572.1% | $13.3M+654.5% | $1.5M-13.6% | $1.8M-24.2% | $1.9M | $1.8M-8.7% |
| Current Assets | $2.3M+84.9% | $2.8M+162.2% | $3.0M+151.1% | $3.4M+226.1% | $1.2M+19.6% | $1.1M-33.5% | $1.2M | $1.0M-11.2% |
| Cash & Equivalents | $24K+261.7% | $155K+483.2% | $7K-96.5% | $657K+3047.4% | $7K-70.3% | $27K-65.5% | $192K | $21K+348.8% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $587K-36.5% | $645K-32.3% | $731K-18.8% | $778K-15.5% | $924K-0.1% | $952K+11.2% | $899K | $921K-17.0% |
| Accounts Receivable | $449K+90.3% | $791K+1259.7% | $12K-85.9% | $570K+1023.8% | $236K+254.0% | $58K-36.8% | $84K | $51K+72.4% |
| Long-Term Investments | $4200.0% | $4200.0% | $420-95.8% | $420-95.8% | $420-95.8% | $420-95.8% | $10K | $10K0.0% |
| Goodwill | $9.8M | $9.8M | $9.8M | $9.8M | N/A | N/A | N/A | N/A |
| Total Liabilities | $26.1M+4.6% | $24.7M+60.3% | $23.5M+84.0% | $23.0M+95.6% | $24.9M+78.8% | $15.4M+21.2% | $12.8M | $11.7M-13.5% |
| Current Liabilities | $25.3M+2.2% | $20.4M+34.5% | $18.9M+50.7% | $18.4M+59.9% | $24.8M+83.1% | $15.1M+23.2% | $12.5M | $11.5M-14.1% |
| Non-Current Liabilities | $761K+384.8% | $4.3M+1630.1% | $4.6M+1762.1% | $4.6M+1748.4% | $157K-62.0% | $248K-39.9% | $248K | $248K+25.2% |
| Long-Term Debt | $20.0M | $19.8M | $19.2M | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$14.9M+36.3% | -$13.2M+3.4% | -$11.8M-9.3% | -$11.4M-14.5% | -$23.4M-92.2% | -$13.6M-31.4% | -$10.8M-4.9% | -$10.0M+14.3% |
| Retained Earnings | -$48.3M+12.5% | -$46.4M-5.7% | -$45.0M-9.3% | -$44.4M-12.4% | -$55.2M-46.6% | -$43.9M-24.8% | -$41.2M | -$39.5M-20.8% |
EDXC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-Q | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$267K-149.9% | $504K+388.3% | -$1.3M-42.2% | -$861K-49.4% | -$107K+90.3% | -$175K+79.5% | -$946K+20.8% | -$576K-469.3% |
| Depreciation & Amortization | $2K-67.3% | $2K-53.6% | $3K-49.7% | $4K-26.1% | $7K+30.2% | $5K0.0% | $5K0.0% | $5K |
| Stock-Based Compensation | N/A | N/A | $107K-64.5% | N/A | N/A | N/A | $300K+1060.1% | N/A |
| Investing Cash Flow | N/A | N/A | N/A | -$583K | $0 | N/A | N/A | N/A |
| Financing Cash Flow | $135K+56.1% | -$355K | $695K-37.8% | $2.1M+264.3% | $87K-91.7% | $0-100.0% | $1.1M-10.9% | $575K+721.4% |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
EDXC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-Q | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.5%-46.0pp | 13.9%-55.1pp | 27.2%+21.3pp | 66.7%-15.5pp | 49.5% | 69.0% | 5.9%-60.0pp | 82.2% |
| Operating Margin | -632.6% | -14.7% | -243.3% | -107.8% | -151.4% | -226.1% | -518.6% | -614.5% |
| Net Margin | -1550.6% | -50.4% | -121.4% | N/A | N/A | -1091.2% | -599.9% | -809.8% |
| Return on Assets | -15.1% | -11.3%+145.9pp | -4.6%+81.1pp | N/A | N/A | -157.1%-96.5pp | -85.7% | -107.9% |
| Current Ratio | 0.090.0x | 0.14+0.1x | 0.16+0.1x | 0.18+0.1x | 0.050.0x | 0.07-0.1x | 0.10 | 0.090.0x |
| Asset Turnover | 0.01-0.3x | 0.22+0.1x | 0.04-0.1x | 0.090.0x | 0.27+0.2x | 0.14+0.1x | 0.14 | 0.13 |
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Note: Shareholder equity is negative (-$11.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.18), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| ENDEXX CORP EDXC | FY2022 | $2.1M | -$4.9M | N/A | $2.1M | — |
| STEMTECH CORP STEK | FY2025 | $2.9M | -$4.0M | N/A | $300K | — |
| CANNAPHARMARX INC CPMD | FY2025 | $1.4M | -$11.1M | N/A | $1.4M | — |
| TILT HLDGS INC TLLTF | FY2024 | $115.6M | -$99.7M | -86.2% | $44K | — |
Where ENDEXX CORP Ranks
Frequently Asked Questions
What is ENDEXX CORP's annual revenue?
ENDEXX CORP (EDXC) reported $2.1M in total revenue for fiscal year 2022. This represents a 228.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is ENDEXX CORP's revenue growing?
ENDEXX CORP (EDXC) revenue grew by 228.7% year-over-year, from $651K to $2.1M in fiscal year 2022.
Is ENDEXX CORP profitable?
No, ENDEXX CORP (EDXC) reported a net income of -$4.9M in fiscal year 2022.
What is ENDEXX CORP's EBITDA?
ENDEXX CORP (EDXC) had EBITDA of -$3.9M in fiscal year 2022, measuring earnings before interest, taxes, depreciation, and amortization.
What is ENDEXX CORP's gross margin?
ENDEXX CORP (EDXC) had a gross margin of 55.8% in fiscal year 2022, indicating the percentage of revenue retained after direct costs of goods sold.
What is ENDEXX CORP's operating cash flow?
ENDEXX CORP (EDXC) recorded an outflow of $2.1M in operating cash flow during fiscal year 2022, representing cash used by core business activities.
What are ENDEXX CORP's total assets?
ENDEXX CORP (EDXC) had $13.3M in total assets as of fiscal year 2022, including both current and long-term assets.
How much does ENDEXX CORP spend on research and development?
ENDEXX CORP (EDXC) invested $27K in research and development during fiscal year 2022.
What is ENDEXX CORP's current ratio?
ENDEXX CORP (EDXC) had a current ratio of 0.18 as of fiscal year 2022, which is below 1.0, which may suggest potential liquidity concerns.
What is ENDEXX CORP's return on assets (ROA)?
ENDEXX CORP (EDXC) had a return on assets of -36.8% for fiscal year 2022, measuring how efficiently the company uses its assets to generate profit.
What is ENDEXX CORP's P/E ratio?
ENDEXX CORP (EDXC) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2022). The market capitalization is $2.1M as of Oct 1, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is ENDEXX CORP's price-to-sales ratio?
ENDEXX CORP (EDXC) trades at 0.4x sales, its market capitalization divided by revenue of $4.6M revenue, trailing 12 months to June 30, 2023. The market capitalization is $2.1M as of Oct 1, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does ENDEXX CORP's liquidity compare with its operating cash outflow?
At the end of fiscal year 2022, ENDEXX CORP (EDXC) held $657K in cash, cash equivalents and investments, and reported an operating cash outflow of $2.1M over that year. Dividing the one by the other, the reported balance equals about 4 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is ENDEXX CORP's debt-to-equity ratio negative or not reported?
ENDEXX CORP (EDXC) has negative shareholder equity of -$11.4M as of fiscal year 2022, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is ENDEXX CORP's Altman Z-Score?
ENDEXX CORP (EDXC) has an Altman Z-Score of -6.80, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is ENDEXX CORP's Piotroski F-Score?
ENDEXX CORP (EDXC) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are ENDEXX CORP's earnings high quality?
ENDEXX CORP (EDXC) reported a net loss of $4.9M while operations used $2.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can ENDEXX CORP cover its interest payments?
ENDEXX CORP (EDXC) reported an operating loss of $3.9M against $1.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.